India's Dr. Lal Pathlabs hits near 8-mnth high on Q1 profit rise

Dr. Lal PathLabs

27/07/2023 11:03

** Shares of Dr. Lal Pathlabs  DLPA.NS  up as much as 3.4%
to 2,499 rupees, their highest since Dec. 6, 2022
    ** Medical diagnostics firm posts ~43% YoY rise in June-qtr
consol net profit to 826 mln rupees ($10.08 mln)
    ** June qtr rev from ops up 7.6% YoY to 5.41 bln rupees 
    ** Over 591,000 shares change hands by 03:29 p.m. IST, 1.6x
the 30-day moving avg
    ** Five of the 20 analysts covering the stock have "buy" or
"strong buy" rating, three have "hold", while 12 recommend
"sell" or "strong sell"; median PT is 1,842.50 rupees -
Refinitiv data
    ** As of last close, stock up ~7% so far this year



($1 = 81.9500 Indian rupees)

 (Reporting by Kashish Tandon in Bengaluru)
 ((Kashish.tandon@thomsonreuters.com))